«Sorafenib (co-developed and co-marketed by Bayer and Onyx Pharmaceuticals as Nexavar),[1] is a kinase inhibitor drug approved for the treatment of primary kidney cancer (advanced renal cell carcinoma), advanced primary liver cancer (hepatocellular carcinoma), FLT3-ITD positive AML and radioactive iodine resistant advanced thyroid carcinoma.» (wikipedia)

  • Subnodes

Modified: 3 months ago on May 25, 2019
personMoreVitaminov 16 lvl added it 3 months ago on May 25, 2019.